Dr. Magda Marquet is founder and co-Chair of Althea Technologies, and served as its co-President and CEO for ten years. Dr. Marquet is also founder and co-Chair of Althea Dx, a spin-off of Althea Technologies focusing in companion diagnostics development and Chairman of BIOCOM. Dr. Marquet has over twenty five years of experience in the biotechnology industry in the United States and Europe. She was formerly Executive Director of Pharmaceutical Development at Vical Incorporated, where she patented several novel methods for the production of clinical grade DNA for use in gene therapy and DNA vaccines. Dr. Marquet holds a Ph.D in Biochemical Engineering from INSA/University of Toulouse, France.